课题基金 / 基金详情

Osteopontin promotes breast cancer recurrence by establishing an inflammatory and fibrotic tumour microenvironment mediated by pro-tumourigenic macrophages and cancer-associated fibroblasts

Osteopontin promotes breast cancer recurrence by establishing an inflammatory and fibrotic tumour microenvironment mediated by pro-tumourigenic macrophages and cancer-associated fibroblasts
骨桥蛋白通过建立由促肿瘤巨噬细胞和癌症相关成纤维细胞介导的炎症和纤维化肿瘤微环境来促进乳腺癌复发
批准号：
475794
负责人：
Gu Yu
金额：
$7.65万
依托单位：
McGill University
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-11-01 至 2025-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=475794&lang=en
关键词：
Breast Cancer Cancer Recurrence Cancer-Associated Fibroblasts Extracellular Matrix Genetically Engineered Mouse Model Immune Regulation Invadopodia Osteopontin Tumour Dormancy Tumour Microenvironment

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
乳腺癌是最有希望的预后之一，但对于八分之一的加拿大女性来说，乳腺癌仍然是第二致命的癌症。其发病率在很大程度上归因于癌症患者的复发，其中大多数人最终将死于CAN。
英文摘要
Breast cancer has one of the most promising prognoses yet remains the second deadliest cancer for one in eight Canadian women. Its morbidity is largely attributed to malignancies returning in patients, most of whom will eventually succumb and die from can
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金